Lv11
40 积分 2022-09-14 加入
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
1小时前
已完结
Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling
7天前
已完结
Modeling relationship of pharmacokinetics, in vitro potency, and α4β7 receptor occupancy with intestinal cell trafficking in a gut-homing mouse model of IBD with MORF-057
23天前
已关闭
Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression
1个月前
已完结
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis
3个月前
已完结
VAV1: a new target in pancreatic cancer?
3个月前
已完结
VAV1: a new target in pancreatic cancer?
3个月前
已关闭
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis
3个月前
已关闭
The haematopoietic specific signal transducer Vav1 is expressed in a subset of human neuroblastomas
3个月前
已完结
IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in AtherosclerosisIRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis
3个月前
已完结
皖公网安备34019202002308
